VerbatimParliament, as it happens

Coronavirus: Medical Treatments

Asked by Munira WilsonLiberal DemocratDepartment of Health and Social CareTabled Answered 19 June 2026UIN 8675

The question

To ask the Secretary of State for Health and Social Care, if he will have discussions with NICE on developing a fast track approval process for covid-19 treatments for the immuno-compromised.

Answered by Preet Kaur Gill

There are no plans to ask the National Institute for Health and Care Excellence (NICE) to establish a fast-track approval process for COVID-19 treatments. NICE evaluates all new licensed medicines, including COVID-19 treatments, and aims wherever possible to issue guidance close to the time of licensing to ensure that National Health Service patients can benefit from rapid access to safe and effective medicines. The aligned pathway between NICE and the Medicines and Healthcare products Regulatory Agency launched on 1 April 2026 and allows decisions on licensing and value to be published in parallel, with the aim of bringing clinically and cost-effective new medicines to patients three to six months sooner.

Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →

Open this question in Verbatim →

Every written question, searchable

155,000 questions tabled since the election, with the answer each department gave — and the ones still unanswered, with the clock running. Free to search.

Search written questions →Read on Verbatim